View Older Stories View More Recent Stories
-
Engene (ENGN) Announces 20M Share Placement at $10/sh
-
enGene Announces Oversubscribed $200 Million Private Placement Financing
-
Pairwise Shares Updated Strategy to Deliver High-Impact Societal and Climate Benefits
-
Cohere Health Raises $50 Million in Equity to Meet Increased Demand for AI-Driven Transformation of Prior Authorization Process
-
Jaguar Gene Therapy Announces FDA Clearance of IND to Study JAG201 in a Genetic Form of Autism Spectrum Disorder and Phelan-McDermid Syndrome
-
Windtree Therapeutics (WINT) Wins $15M Contingent Liability To Deerfield Management Company
-
Windtree Therapeutics (NASDAQ:WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company
-
Element Science Receives CE Mark & UKCA Mark for the Jewel® Patch-Wearable Cardioverter Defibrillator
-
Windtree (WINT) Eliminates $15M Contingent Liability to Deerfield Management Company
-
Windtree Eliminates $15 Million Contingent Liability to Deerfield Management Company
-
Endologix Announces that Art Taylor Joins Board of Directors
-
Kura Oncology (KURA) Prices 1.38M Share Offering at $17.25/sh
-
Kura Oncology Announces Oversubscribed $150 Million Private Placement
-
CalciMedica (CALC) Announces Private Placement of up to Approximately $55 Million
-
CalciMedica Announces Private Placement of up to Approximately $55 Million
-
Edgewise Therapeutics (EWTX) Prices $240 Million Underwritten Offering of Common Stock
-
Edgewise Therapeutics Announces Pricing of $240 Million Underwritten Offering of Common Stock
-
Advanced Medicine Partners Launches to Set New Standard for Manufacturing and Testing Advanced Medicines
-
Washington University and Deerfield Management Launch VeritaScience to Drive Drug Discovery
-
San Francisco Witnesses the Voice of GCT Titans GenScript Biotech Global Forum Outlines the Future of the Industry
-
MMI and ab medica Partner to Expand Access to Symani® Surgical System
-
Endologix Announces that Scott Ward Joins Board of Directors
-
Solid Biosciences (SLDB) Enters $108.9M Private Placement
-
Solid Biosciences Announces $109 Million Private Placement
-
MMI to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Apertura Gene Therapy Unveils Novel Engineered AAV Capsids Targeting Human Transferrin Receptor 1 for Neurological Gene Therapy Delivery
-
GenScript Biotech Global Forum 2024 to Commence, Infusing New Vitality into the GCT Industry
-
Valneva Provides Updated 2023 Financial Guidance
-
Endologix announces the U. S. Centers for Medicare & Medicaid Services granted a Transitional Pass-Through (TPT) Payment for the DETOUR™ System
-
FDA Keynote Speaker in the Spotlight, CAR-T Industry Leaders Gather for Discussion-Join the 2024 GenScript Biotech Global Forum for a New Journey in Cell and Gene Therapy
-
Moving Minds Selected as One of the Top SEO Companies in U.S. by RankWatch
-
Adela Appoints Precision Medicine Veteran Lisa Alderson as CEO
-
Titans Gather, Future Embarks: The GenScript Biotech Global Forum coinciding with the 2024 J.P. Morgan Healthcare Conference in San Francisco to Convene 20+ KOLs, Exploring Disruptive Transformations
-
Bicara Therapeutics Announces Oversubscribed $165 Million Series C Financing
-
Deerfield Foundation Awards More Than $1.4 Million to Improve Health, Accelerate Innovation and Promote Equity
-
Publication Relating to a Transparency Notification
-
CRISPR Continuous to Innovate! Exploring the Future of Cell & Gene Therapy, Industry Leaders Converge at the 2024 GenScript Biotech Global Forum
-
Adela Presents Data Demonstrating Strong Prognostic Prediction Capabilities in Lung Cancer at the 2023 Multidisciplinary Thoracic Cancers Symposium
-
Form 4 CareMax, Inc. For: Nov 17 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Oscar Health (OSCR) Reports Mark Bertolini’s Foundation and Deerfield Management have Agreed with a Selling Shareholder to Purchase Shares of Oscar Health
-
Oscar Health, Inc. Announces that Mark Bertolini’s Foundation and Deerfield Management have Entered into an Agreement with a Selling Shareholder to Purchase Shares of Oscar Health
-
Form 13F-HR DEERFIELD MANAGEMENT For: Sep 30
-
Element Science Announces Presentation of Successful Results of the Jewel® IDE Study in a Featured Science Presentation at the American Heart Association’s 2023 Annual Scientific Sessions
-
Endologix to Present in Two Upcoming Healthcare Conferences
-
Valneva Reports Nine-Month 2023 Financial Results and Provides Corporate Updates
-
Sfunga Therapeutics and Deerfield Management Announce Publication on Novel Antifungal SF001 in Nature
-
Endologix Announces Results of Pooled Analysis of DETOUR1 and DETOUR2 Studies at 2023 VIVA Late-Breaking Clinical Trial Session
-
CYSTETIC MEDICINES DOSES FIRST PERSON WITH CYSTIC FIBROSIS IN PHASE 1 TRIAL OF INVESTIGATIONAL THERAPY CM001, DESIGNED TO FORM ION CHANNELS TO HELP RESTORE AIRWAY FUNCTION
-
Endologix's DETOUR™ System Earns Spot in Local and National Award Forums; Nominated for Prix Galien USA's Best Medical Technology
-
Adela Presents Data Demonstrating Strong Prognostic Prediction Capabilities in Head and Neck Cancer and Renal Cell Carcinoma at the ESMO 2023 Congress
